AMICAR (Avera McKennan Hospital)
Welcome to the PulseAid listing for the AMICAR drug offered from Avera McKennan Hospital. This Antifibrinolytic Agent [EPC],Decreased Fibrinolysis [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Avera McKennan Hospital |
| NON-PROPRIETARY NAME: | Aminocaproic Acid |
| SUBSTANCE NAME: | AMINOCAPROIC ACID |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Antifibrinolytic Agent [EPC],Decreased Fibrinolysis [PE] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-09-23 |
| END MARKETING DATE: | 0000-00-00 |
AMICAR HUMAN PRESCRIPTION DRUG Details:
| Item Description | AMICAR from Avera McKennan Hospital |
| LABELER NAME: | Avera McKennan Hospital |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 500(mg/1) |
| START MARKETING DATE: | 2015-09-23 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69189-0354_50aafeb4-b6d0-4ee0-ade3-6356d05084ab |
| PRODUCT NDC: | 69189-0354 |
| APPLICATION NUMBER: | NDA015197 |
Other AMINOCAPROIC ACID Pharmaceutical Manufacturers / Labelers:
